As the public health emergency around COVID-19 creeps closer to an end, drugmakers have only begun to duke it out in court over patent rights to the billion-dollar vaccines. Arbutus Biopharma and ...
While Arbutus Biopharma is busy scrapping with Moderna and Pfizer over COVID-19 vaccine patents, Moderna has chalked up a win in a separate case. Back in 2018, Moderna challenged one of Arbutus’ lipid ...
Roivant Sciences and Moderna Therapeutics, two of the most highly-funded and controversial companies in the biotechnology world, are headed for a collision course over medical technology. On Monday, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback